Bac2 Raises 2 million Pounds for Ground-Breaking Fuel Cell Technology

Fuel cell materials company Bac2 has raised £2 million of private funding from London Business Angels, enabling the company to commercialise and take to market its ground-breaking conductive polymer ‘ElectroPhen’. The material is a key enabler to the uptake and success of fuel cells as a future solution to clean energy needs and will propel the commercialisation of fuel cell technology. The investment is testament to the success of the business after raising £500,000 seed investment in May 2006 and an earlier £250,000 UK Department of Trade and Industry (DTI) grant.

The latest funding round was led by London Seed Capital and London Business Angels who supported the continuing success of their original investment in 2006 raising £2 million for this round. The investment is the largest ever Business Angel investment in the 25 year history of the London network.

Bac2’s CEO, Mike Stannard, commented, “The fact that we have been able to secure so much investment, primarily from private individuals, demonstrates the progress we have made since the company was set up in 2005. We now understand how the unique properties of ElectroPhen can be most effectively commercialised, initially in the fuel cell markets and in other electrical and electronics applications.”

Jason Ball of London Seed Capital added, “Clean technology is one of the most exciting opportunities for investors today. Bac2 has turned its vision of ElectroPhen as a fuel cell material into reality and is already sampling bipolar plates around the world. What’s particularly exciting is that this material has the potential to make a real difference to the speed at which clean technologies are adopted.”

Bac2 is planning to announce its first standard product shortly and is planning a number of new opportunities for ElectroPhen, including its use in plastic/printed electronic components and circuits.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.